Project Description

NAT has been established in June 2016 in Terrassa, Spain as an R&D entity hiring Lab facilities in LEITAT Technology Center (Terrassa, Barcelona, Spain). NAT is developing at the Lab scale clathrates of small organic molecules (molecular complexes of organic molecules with cyclodextrin molecular cages) as new antimicrobial complexes. Pilot scale production is under way with industrial third partners. NAT is also developing nanoemulsion technology designed for targeting multiresistant microbes.